CYTOVALE INC. — Form D/A
CYTOVALE INC. of SAN FRANCISCO, CA, a company, filed a Form D amendment with the SEC on 2022-01-03. The offering totals $20.0M, of which $16.4M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2022-01-03
- Form: D/A
- Accession: 0001725779-21-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $20.0M
- Amount sold: $16.4M
- Remaining: $3.6M
- Investors: 23
- Date of first sale: 2020-12-18
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-385088
Issuer
- Name: CYTOVALE INC.
- CIK: 0001725779
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 150 EXECUTIVE PARK BLVD, SUITE 4100, SAN FRANCISCO, CA, 94134
- Phone: (562) 881-6919
Officers, directors & promoters (11)
| Name | Role | Location |
|---|
| Dino DiCarlo | Director | San Francisco, CA |
| Lindy Fishburne | Director | Anaheim, CA |
| JACK FUCHS | Director | BURLINGAME, CA |
| Jordanna Polis Schutz | Director | San Francisco, CA |
| Ajay Shah | Director | San Francisco, CA |
| William Blackledge | Executive Officer | San Francisco, CA |
| Ajay Shah | Executive Officer | San Francisco, CA |
| Henry Tse | Executive Officer | San Francisco, CA |
| Dino DiCarlo | Promoter | San Francisco, CA |
| JACK FUCHS | Promoter | BURLINGAME, CA |
| Ajay Shah | Promoter | San Francisco, CA |
Other filings by this issuer (3)
More